Centaurus Financial Inc. acquired a new stake in shares of Docusign Inc. (NASDAQ:DOCU – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 27,030 shares of the company’s stock, valued at approximately $1,201,000.
Several other hedge funds have also recently modified their holdings of the company. BlackRock Inc. purchased a new position in shares of Docusign in the 2nd quarter worth about $927,059,000. State Street Corp grew its stake in Docusign by 0.9% in the 4th quarter. State Street Corp now owns 8,193,805 shares of the company’s stock valued at $560,456,000 after buying an additional 77,008 shares in the last quarter. Capital World Investors raised its holdings in Docusign by 38.1% during the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock valued at $397,801,000 after acquiring an additional 1,603,900 shares during the period. Arrowstreet Capital Limited Partnership lifted its position in shares of Docusign by 76.1% during the first quarter. Arrowstreet Capital Limited Partnership now owns 5,285,128 shares of the company’s stock worth $250,568,000 after acquiring an additional 2,283,996 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Docusign by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 4,084,463 shares of the company’s stock worth $278,665,000 after acquiring an additional 18,873 shares in the last quarter. Institutional investors own 77.64% of the company’s stock.
Analysts Set New Price Targets
A number of research firms recently issued reports on DOCU. BTIG Research decreased their price objective on Docusign from $70.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Weiss Ratings upgraded Docusign from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday. Wells Fargo & Company lowered their price target on shares of Docusign from $60.00 to $55.00 and set an “equal weight” rating on the stock in a report on Friday, June 5th. Citizens Jmp reaffirmed a “market outperform” rating and set a $86.00 price objective on shares of Docusign in a research note on Tuesday, August 18th. Finally, Jefferies Financial Group upped their target price on shares of Docusign from $45.00 to $50.00 and gave the stock a “hold” rating in a report on Friday, June 5th. Four equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $60.27.
Docusign Stock Up 7.5%
NASDAQ:DOCU opened at $63.80 on Friday. The stock has a market cap of $12.18 billion, a P/E ratio of 41.43, a PEG ratio of 1.72 and a beta of 0.87. The business’s 50-day moving average price is $53.03 and its two-hundred day moving average price is $49.04. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $86.65.
Docusign (NASDAQ:DOCU – Get Free Report) last issued its quarterly earnings data on Thursday, June 4th. The company reported $1.09 EPS for the quarter, topping the consensus estimate of $0.99 by $0.10. The company had revenue of $830.24 million during the quarter, compared to analyst estimates of $824.71 million. Docusign had a return on equity of 17.48% and a net margin of 9.59%.Docusign’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.90 earnings per share. On average, equities research analysts expect that Docusign Inc. will post 2.06 EPS for the current fiscal year.
Insider Transactions at Docusign
In other news, CFO Blake Jeffrey Grayson sold 15,000 shares of the firm’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $60.00, for a total transaction of $900,000.00. Following the sale, the chief financial officer owned 126,429 shares in the company, valued at approximately $7,585,740. This trade represents a 10.61% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider James P. Shaughnessy sold 12,000 shares of Docusign stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total transaction of $546,480.00. Following the sale, the insider directly owned 52,815 shares of the company’s stock, valued at $2,405,195.10. This represents a 18.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 91,330 shares of company stock worth $4,357,737. Company insiders own 0.59% of the company’s stock.
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
See Also
- Five stocks we like better than Docusign
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
